Immunosuppression is mediated by cancer cells expressing programmed death-ligand 1 (PD-L1) and CD80 that bind PD-1 and cytotoxic T-lymphocyte-associated protein 4 (CTLA4) on cytotoxic T cells to suppress T cell activation [7]. This evidence concerns the gene CD80 and cancer.